Biomolecules & Therapeutics 2023; 31(1): 139-139
Erratum to "Synthetic Homoisoflavane Derivatives of Cremastranone Suppress Growth of Colorectal Cancer Cells through Cell Cycle Arrest and Induction of Apoptosis" [Biomol. Ther. 30 (2022) 576-584]
Ha-Eun Shin1,†, Seul Lee2,†, Yeram Choi1, Sangkyu Park3, Sangil Kwon2, Jun-Kyu Choi3, Seung-Yong Seo2,* and Younghee Lee1,3,*
1Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 28644,
2College of Pharmacy, Gachon University, Incheon 21936,
3Biotechnology Research Institute, Chungbuk National University, Cheongju 28644, Republic of Korea
*E-mail: (Lee Y), (Seo SY)
Tel: +82-43-261-3387 (Lee Y), +82-32-820-4949 (Seo SY)
Fax: +82-43-267-2306 (Lee Y), +82-32-820-4829 (Seo SY)
The first two authors contributed equally to this work.

DOI of original article :
Published online: December 19, 2022.
© The Korean Society of Applied Pharmacology. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

The authors request to correct the structure of SH-19017 in Fig. 1B on page 579. The authors synthesized a variety of creamstranone derivatives and unintentionally presented the structure of another compound. As SH-19017 had no cytotoxic effect as shown in Supplementary Fig. 2, this error does not affect the conclusion of the article. However, the authors apologize for this accidental error and inconvenience.

Figure 1. Structure of cremastranone and homoisoflavane derivatives. (A) Natural product cremastranone and synthetic homoisoflavane SH-17059, (B) A-ring modification of SH-17059, and (C) B-ring modification of SH-17059.

This Article

Cited By Articles
  • CrossRef (0)

Social Network Service